Characterization of opioid use in sickle cell disease.

Jin HanJifang ZhouSantosh L SarafVictor R GordeukGregory Sampang Calip

Published in: Pharmacoepidemiology and drug safety (2017)

Our study showed that only 40% SCD patients were on opioid analgesics during a 12-month span. However, a non-trivial number of patients used a much higher dose of opioids despite a relatively low average daily opioid dose among SCD patients, particularly with vaso-occlusive complications.

Keyphrases

end stage renal disease
sickle cell disease
ejection fraction
chronic kidney disease
newly diagnosed
chronic pain
prognostic factors
peritoneal dialysis
physical activity
patient reported